GO:0160226 oligosaccharyltransferase complex A: Components, Assembly and Research Methods, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0160226 (oligosaccharyltransferase complex A, OST-A) is a cellular_component defined by the presence of STT3A as its catalytic subunit.
• OST-A catalyzes the en bloc transfer of a preassembled oligosaccharide from dolichol-linked donors onto asparagine residues of nascent polypeptides at the endoplasmic reticulum.
• The complex is composed of STT3A, RPN1, RPN2, MAGT1, TUSC3, DDOST, and OST4, with additional accessory proteins such as TMEM258 and DAD1.
• Loss of OST-A function causes a congenital disorder of glycosylation (CDG) with multisystem phenotypes, including intellectual disability and seizures.
• CRISPR knockout screens have shown that OST-A subunits are essential in human haploid cells, and positive selection screens identified a druggable pocket in an OST subunit required for inflammatory NF-kB signaling.
• Research on OST-A uses CRISPR KO/point-mutation/knock-in models, Ribo-seq, proteomics, and imaging to dissect its role in protein biogenesis and disease.
Description
Oligosaccharyltransferase complex A (OST-A) is a multi-subunit enzyme complex anchored in the endoplasmic reticulum (ER) membrane that carries out the central step of N-linked glycosylation: the transfer of a preassembled oligosaccharide from a dolichol-linked donor to asparagine residues within the sequon Asn-X-Ser/Thr of nascent polypeptides. The complex is defined by the presence of STT3A as its catalytic subunit, distinguishing it from the paralogous OST-B complex that uses STT3B. OST-A is conserved across eukaryotes and is essential for protein folding, quality control, and trafficking in the secretory pathway. For researchers, OST-A is a focal point because its dysfunction is linked to congenital disorders of glycosylation (CDG) and because recent CRISPR screens have revealed that OST-A subunits are required for inflammatory signaling and are essential in haploid human cells. The complex also represents a potential therapeutic target in aggressive lymphomas and other malignancies where N-linked glycosylation is dysregulated. Understanding OST-A structure, assembly, and regulation is therefore critical for both basic cell biology and translational medicine. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0160226, covering its definition, composition, molecular mechanism, disease relevance, and the CRISPR-based methods used to study it.
oligosaccharyltransferase complex A At A Glance
| GO ID | GO:0160226 |
|---|---|
| GO term | oligosaccharyltransferase complex A |
| Ontology | cellular_component |
| Synonym | OST-A |
| Major function | Catalyzes the transfer of a preassembled oligosaccharide from dolichol-linked donors to asparagine residues of nascent polypeptides |
| Catalytic subunit | STT3A |
| Localization | Endoplasmic reticulum membrane |
| Associated disease | Congenital disorder of glycosylation (CDG) |
| Essentiality | Essential in human haploid cells |
What Is GO:0160226?
According to the Gene Ontology, GO:0160226 (oligosaccharyltransferase complex A) is a cellular_component defined as an oligosaccharyltransferase complex that contains STT3A as the catalytic subunit. This definition distinguishes OST-A from OST-B, which contains STT3B. The complex is localized to the endoplasmic reticulum membrane and functions in the co-translational N-glycosylation of nascent polypeptides.
Why Is oligosaccharyltransferase complex A Important in Cell Biology?
OST-A is essential for the N-linked glycosylation of a large fraction of the proteome, influencing protein folding, stability, and trafficking. Its dysfunction causes a congenital disorder of glycosylation with severe multisystem phenotypes, and its activity is required for inflammatory NF-kB signaling, making it a potential drug target. Moreover, OST-A subunits are essential genes in human cells, underscoring their fundamental role in cell viability.
• OST-A mediates co-translational N-glycosylation of nascent polypeptides at the ER.
• It is required for proper protein folding and quality control in the secretory pathway.
• Mutations in OST-A subunits cause a congenital disorder of glycosylation (CDG).
• OST-A is essential for inflammatory signaling to NF-kB, and a druggable pocket in an OST subunit has been identified.
• CRISPR knockout screens show OST-A subunits are essential in human haploid cells.
• Targeting N-linked glycosylation, including OST-A, is a therapeutic strategy in aggressive lymphomas.
• OST-A is a model system for studying multi-subunit membrane protein complexes and their assembly.
• Its structure has been resolved by cryo-EM, revealing atomic details of the eukaryotic OST complex.
• OST-A function can be probed by Ribo-seq and proteomics to assess glycosylation efficiency.
• Dysregulation of OST-A is linked to cancer and developmental disorders.
What Happens During oligosaccharyltransferase complex A?
Recognition of the sequon on nascent polypeptides
In simple terms: The enzyme scans new proteins as they emerge from the ribosome and looks for a specific three-amino-acid tag.
OST-A associates with the translocon and engages nascent polypeptides as they enter the ER lumen. It recognizes the sequon Asn-X-Ser/Thr, where X is any amino acid except proline, and positions the asparagine for glycosylation. This co-translational recognition ensures that glycosylation occurs before protein folding is complete.
Dolichol-linked oligosaccharide donor binding
In simple terms: A lipid-linked sugar chain is delivered to the enzyme to be transferred onto the protein.
The donor substrate is a preassembled oligosaccharide (Glc3Man9GlcNAc2) linked to dolichol phosphate. OST-A binds this dolichol-linked donor and positions it for transfer to the acceptor asparagine. The lipid moiety anchors the donor in the ER membrane, facilitating the en bloc transfer.
Catalysis by STT3A
In simple terms: The catalytic subunit STT3A performs the actual chemical reaction that attaches the sugar chain to the protein.
STT3A is the catalytic subunit of OST-A and contains the conserved WWDYG motif essential for catalysis. It catalyzes the transfer of the oligosaccharide from the dolichol donor to the asparagine side chain, forming an N-glycosidic bond. This reaction occurs on the luminal side of the ER membrane.
Release and quality control
In simple terms: After the sugar is attached, the protein is checked for proper folding and can move forward in the cell.
Following glycosylation, the nascent glycoprotein is released from OST-A and enters the calnexin/calreticulin cycle for folding and quality control. Properly folded proteins traffic to their destinations, while terminally misfolded glycoproteins are retrotranslocated for ER-associated degradation. OST-A thus couples glycosylation to protein homeostasis.
Key Genes Involved in GO:0160226 oligosaccharyltransferase complex A
The following genes encode the major subunits and accessory proteins of the oligosaccharyltransferase complex A (GO:0160226).
| Gene | Major Role | Research Relevance |
|---|---|---|
| STT3A | Catalytic subunit of OST-A; transfers oligosaccharide to asparagine | Target for glycosylation studies; essential gene |
| RPN1 | Non-catalytic subunit; binds dolichol-linked donor | Structural component; potential drug target |
| RPN2 | Non-catalytic subunit; stabilizes complex | Required for OST-A assembly and function |
| MAGT1 | Accessory subunit; involved in magnesium homeostasis and glycosylation | Mutations cause immunodeficiency |
| TUSC3 | Accessory subunit; paralog of MAGT1 | Linked to intellectual disability |
| DDOST | Non-catalytic subunit; also known as OST48 | CDG-causing gene |
| OST4 | Small subunit; essential for complex stability | Conserved across eukaryotes |
| TMEM258 | Accessory subunit; modulates OST-A activity | Potential regulator of glycosylation |
| DAD1 | Accessory subunit; prevents apoptosis | Essential for complex integrity |
| STT3B | Catalytic subunit of OST-B (paralog) | Distinct from OST-A; used for comparison |
| SEC61A1 | Translocon subunit interacting with OST-A | Links translation to glycosylation |
| RPN1 | Dolichol recognition | Structural studies |
| RPN2 | Complex assembly | Structural studies |
| MAGT1 | Immunity and glycosylation | CDG models |
| TUSC3 | Neurodevelopment | CDG models |
| DDOST | CDG | CDG models |
| OST4 | Complex stability | Structural studies |
| TMEM258 | Regulation | Functional studies |
How Is oligosaccharyltransferase complex A Regulated?
OST-A activity is regulated at multiple levels. The complex associates with the translocon and is influenced by the rate of protein translation and ER stress. Regulated N-glycosylation controls chaperone function and receptor trafficking, indicating that OST-A activity can be modulated by cellular signaling. Additionally, the unfolded protein response (UPR) can alter glycosylation capacity to maintain ER homeostasis. Specific regulatory subunits such as TMEM258 may modulate OST-A stability or activity.
oligosaccharyltransferase complex A and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DDOST | Congenital disorder of glycosylation (CDG) | Knockout or point-mutation iPSC-derived neurons |
| MAGT1 | Immunodeficiency and CDG | Knockout T cells or patient-derived fibroblasts |
| TUSC3 | Intellectual disability and CDG | Knockout mouse models or neuronal cultures |
| STT3A | Essential for cell viability; cancer | CRISPR knockout in cancer cell lines |
| RPN1 | Inflammatory signaling to NF-kB | Positive selection CRISPR screens in lymphoma cells |
Congenital disorders of glycosylation (CDG)
Mutations in OST-A subunits, including DDOST, MAGT1, and TUSC3, cause congenital disorders of glycosylation with multisystem phenotypes such as intellectual disability, seizures, and immune dysfunction. These disorders highlight the critical role of OST-A in development and physiology.
Cancer and inflammatory signaling
OST-A is required for inflammatory signaling to NF-kB, and a druggable pocket in an OST subunit has been identified, suggesting that OST-A inhibitors could be developed for inflammatory diseases and cancers. Targeting N-linked glycosylation, including OST-A, has shown promise in aggressive lymphomas.
Essentiality and cell viability
CRISPR knockout screens in human haploid cells have demonstrated that OST-A subunits are essential genes, indicating that loss of OST-A function impairs cell viability. This essentiality underscores the importance of OST-A in basic cellular processes.
From oligosaccharyltransferase complex A-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is STT3A essential for cell viability? | CRISPR knockout in haploid HAP1 cells |
| Does a point mutation in STT3A abolish glycosylation? | Point-mutation knock-in in HEK293T cells |
| How does OST-A assembly affect complex stability? | Knock-in of tagged subunits (e.g., GFP-STT3A) |
| Can OST-A be targeted for cancer therapy? | Overexpression of OST-A subunits in lymphoma cells |
| What is the role of OST-A in NF-kB signaling? | CRISPR knockout of RPN1 in macrophages |
| How does OST-A dysfunction cause CDG? | Patient-derived iPSCs with DDOST mutations |
How to Study the oligosaccharyltransferase complex A Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Translation efficiency and ribosome occupancy | Assess impact of OST-A loss on protein synthesis |
| Glycoproteomics | N-glycosylation site occupancy | Identify OST-A-dependent glycoproteins |
| Cryo-EM | 3D structure of OST-A complex | Determine subunit arrangement and catalytic site |
| CRISPR knockout screens | Gene essentiality and synthetic lethality | Identify OST-A as essential gene |
| Positive selection CRISPR screens | Pathway-specific requirements | Find druggable pocket in OST subunit |
| Western blot | Protein expression and glycosylation status | Validate CDG mutations |
| Immunofluorescence | Subcellular localization | Confirm ER localization of OST-A |
| Flow cytometry | Cell surface receptor trafficking | Measure OST-A-dependent receptor maturation |
Ribo-seq and translatome profiling
Ribo-seq can measure translation efficiency and identify changes in glycosylation capacity upon OST-A perturbation. It reveals how OST-A dysfunction affects the synthesis of secreted and membrane proteins.
Proteomics and glycoproteomics
Mass spectrometry-based glycoproteomics can quantify site-specific N-glycosylation occupancy and identify proteins whose glycosylation depends on OST-A. This approach is useful for assessing the impact of OST-A mutations.
Cryo-EM and structural biology
Cryo-electron microscopy has resolved the atomic structure of the eukaryotic OST complex, revealing subunit organization and the catalytic site. Structural studies guide mutational analysis of OST-A function.
CRISPR screens and functional genomics
Genome-wide CRISPR knockout and positive selection screens have identified OST-A subunits as essential and required for specific signaling pathways. These screens can uncover context-dependent vulnerabilities.
How CRISPR Can Be Used to Study GO:0160226 oligosaccharyltransferase complex A
Knockout
CRISPR knockout of OST-A subunits such as STT3A or RPN1 can abolish N-glycosylation and is lethal in many cell types, as shown by haploid screens. Knockout models are used to study essentiality and identify compensatory pathways.
Point Mutation
Point mutations in the catalytic WWDYG motif of STT3A can be introduced to dissect catalytic mechanism without disrupting complex assembly. Such models help distinguish catalytic activity from structural roles.
Knock-in
Knock-in of epitope-tagged OST-A subunits (e.g., GFP-STT3A) enables affinity purification and imaging of the complex in live cells. This approach is valuable for studying assembly and dynamics.
Overexpression
Overexpression of OST-A subunits can enhance glycosylation capacity and is used to study gain-of-function phenotypes in cancer cells. It can also rescue knockout phenotypes.
How EDITGENE Supports oligosaccharyltransferase complex A Research
Researchers studying oligosaccharyltransferase complex A-related genes often need to determine whether a candidate gene is causally involved in glycosylation, protein trafficking, or disease. EDITGENE provides a comprehensive suite of CRISPR services to generate precisely engineered cell models for such investigations.
Contact EDITGENE today to design your custom CRISPR model for oligosaccharyltransferase complex A research.
Frequently Asked Questions About oligosaccharyltransferase complex A
What is oligosaccharyltransferase complex A (GO:0160226)?
It is a cellular_component defined as an oligosaccharyltransferase complex that contains STT3A as the catalytic subunit, responsible for N-linked glycosylation of nascent polypeptides.
What genes are involved in oligosaccharyltransferase complex A?
Key genes include STT3A, RPN1, RPN2, MAGT1, TUSC3, DDOST, OST4, TMEM258, and DAD1.
What is the function of STT3A in OST-A?
STT3A is the catalytic subunit that transfers the oligosaccharide from dolichol-linked donors to asparagine residues.
How is OST-A different from OST-B?
OST-A contains STT3A, while OST-B contains STT3B; they have distinct substrate specificities and functions.
What diseases are associated with OST-A mutations?
Mutations in OST-A subunits cause congenital disorders of glycosylation (CDG) with symptoms like intellectual disability and immune dysfunction.
Is OST-A essential for cell survival?
Yes, CRISPR knockout screens in human haploid cells have shown that OST-A subunits are essential genes.
How can I study OST-A in the lab?
You can use CRISPR knockout, point mutations, knock-in tags, Ribo-seq, glycoproteomics, and cryo-EM.
What is the role of OST-A in cancer?
OST-A is required for inflammatory NF-kB signaling and is a potential therapeutic target in aggressive lymphomas.
What are the subunits of OST-A?
The complex includes STT3A, RPN1, RPN2, MAGT1, TUSC3, DDOST, OST4, and accessory proteins.
How does OST-A regulate protein folding?
By adding N-glycans co-translationally, OST-A facilitates proper folding and quality control in the ER.
Conclusion
Oligosaccharyltransferase complex A (GO:0160226) is a central enzyme in the N-linked glycosylation pathway, defined by its catalytic subunit STT3A. Its essential role in protein biogenesis, its link to congenital disorders of glycosylation, and its emerging importance in cancer and inflammation make it a compelling research target. Advances in CRISPR engineering, structural biology, and glycoproteomics continue to illuminate its mechanism and therapeutic potential. EDITGENE offers a full range of CRISPR services to support mechanistic and translational studies of OST-A, from knockout and point-mutation models to library screening and bioinformatics.
References
- 1. Ma M et al.. 2024. Regulated N-glycosylation controls chaperone function and receptor trafficking.. Science 386(6722):667-672 PMID: 39509507
- 2. Yan Q et al.. 1999. Oligosaccharyltransferase: a complex multisubunit enzyme of the endoplasmic reticulum.. Biochem Biophys Res Commun 266(3):684-9 PMID: 10603306
- 3. Lampson BL et al.. 2024. Positive selection CRISPR screens reveal a druggable pocket in an oligosaccharyltransferase required for inflammatory signaling to NF-κB.. Cell 187(9):2209-2223.e16 PMID: 38670073
- 4. Blomen VA et al.. 2015. Gene essentiality and synthetic lethality in haploid human cells.. Science 350(6264):1092-6 PMID: 26472760
- 5. Gemmer M et al.. 2023. Visualization of translation and protein biogenesis at the ER membrane.. Nature 614(7946):160-167 PMID: 36697828
- 6. Bryant EM et al.. 2020. Oligosaccharyltransferase complex-congenital disorders of glycosylation: A novel congenital disorder of glycosylation.. Am J Med Genet A 182(6):1460-1465 PMID: 32267060
- 7. Bai L et al.. 2018. The atomic structure of a eukaryotic oligosaccharyltransferase complex.. Nature 555(7696):328-333 PMID: 29466327
- 8. Scheich S et al.. 2023. Targeting N-linked Glycosylation for the Therapy of Aggressive Lymphomas.. Cancer Discov 13(8):1862-1883 PMID: 37141112
